Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 12
Author(s): L. Ballerini
Affiliation:
Export Options
About this article
Cite this article as:
Ballerini L. , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (12) . https://dx.doi.org/10.2174/1570159X1712191028162518
DOI https://dx.doi.org/10.2174/1570159X1712191028162518 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
19
4
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Matching Intervention to Need in Juvenile Justice: The CASII Level of Care Determination
Adolescent Psychiatry Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain
Current Pharmaceutical Design Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters Lipoprotein (a) and Cardiovascular Risk: The Show Must go on
Current Medicinal Chemistry Histamine in Immune Regulation: Possible Roles in Autoimmune Demyelinating Disease of the Central Nervous System
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Interference of Metals and Medications with the Detection of Lipid Peroxidation in Humans by Photometric TBARS Assay
Current Analytical Chemistry Regulation of Stem Cell-Based Research in India in Comparison with the US, EU and other Asian Countries: Current Issues and Future Perspectives
Current Stem Cell Research & Therapy Preface
Current Medicinal Chemistry Commentary 2 (The Contribution of Glial Cells and Water Channel Aquaporin-4 in the Neuropathology of Cardiac Arrest is Still Ignored)
CNS & Neurological Disorders - Drug Targets Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets Enhancing Evidence Based Practice Implementation: Defining, Training and Evaluating Therapist Competence at Treating Youth Psychiatric Disorders
Adolescent Psychiatry Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom
Current Medicinal Chemistry Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets From Axonal Transport to Mitochondrial Trafficking: What Can We Learn from Manganese-Enhanced MRI Studies in Mouse Models of Alzheimers Disease?
Current Medical Imaging Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research Molecular Recognition in the Case of Flexible Targets
Current Pharmaceutical Design Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3
Current Neuropharmacology Immunotherapy for Conformational Diseases
Current Pharmaceutical Design MicroRNA-130b Promotes Wear Particle-Induced Osteolysis via Downregulating Frizzled-Related Protein (FRZB)
Current Neurovascular Research In Vivo Uptake of β-Amyloid by Non-Plaque Associated Microglia
Current Alzheimer Research